Compare Edwards Lifesciences Corporation Common Stock (EW) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Rocket Lab USA Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.1 (market cap $48.56B), while Rocket Lab USA Inc trades at $67.64 (market cap $43.74B). The key difference: Edwards Lifesciences Corporation Common Stock and Rocket Lab USA Inc are close in size by market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| EW | RKLB | |
|---|---|---|
Market Cap | $48.56B | $43.74B |
Volume | 6,520,488 | 22,892,581 |
Sector | Health | Industrials |
52-Week High | $95.18 | $150.23 |
52-Week Low | $72.65 | $39.48 |
Enterprise Value | $45.01B | $41.57B |
Typical Hold Time | — | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rocket Lab (RKLB) trades at $71.92, down 4.18% today, with neutral technical signals and strong analyst support. The company recently secured its largest commercial Electron deal - 20 launches with Synspective - boosting its backlog past 100 missions. Despite negative profitability metrics, revenue growth continues with 2026 projections showing improvement from 2025's $602 million. The stock trades at elevated valuation multiples with P/S of 51.96 and P/B of 12.52.
RKLB presents a growth story with significant contract wins and expanding launch capacity, though profitability remains elusive. The 76% analyst buy rating and $107 consensus target suggest substantial upside potential. Key risks include intense SpaceX competition, high cash burn, and valuation concerns. Investors must weigh growth trajectory against persistent losses and competitive pressures in the evolving space industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
